Correlation Between Cannara Biotech and Pharmadrug

Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and Pharmadrug at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and Pharmadrug into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannara Biotech and Pharmadrug, you can compare the effects of market volatilities on Cannara Biotech and Pharmadrug and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of Pharmadrug. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and Pharmadrug.

Diversification Opportunities for Cannara Biotech and Pharmadrug

-0.31

Correlation Coefficient

Cannara Biotech  Pharmadrug

Very good diversification

The 3 months correlation between Cannara and Pharmadrug is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and Pharmadrug in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmadrug and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with Pharmadrug. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmadrug has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and Pharmadrug go up and down completely randomly.

Pair Corralation between Cannara Biotech and Pharmadrug

Assuming the 90 days horizon Cannara Biotech is expected to generate 4.4 times less return on investment than Pharmadrug. But when comparing it to its historical volatility, Cannara Biotech is 3.23 times less risky than Pharmadrug. It trades about 0.04 of its potential returns per unit of risk. Pharmadrug is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1.62  in Pharmadrug on September 14, 2024 and sell it today you would lose (0.58) from holding Pharmadrug or give up 35.8% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cannara Biotech  vs.  Pharmadrug

Cannara Biotech

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Cannara Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Pharmadrug

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pharmadrug are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Pharmadrug reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cannara Biotech and Pharmadrug

The main advantage of trading using opposite Cannara Biotech and Pharmadrug positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, Pharmadrug can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmadrug will offset losses from the drop in Pharmadrug's long position.

The idea behind Cannara Biotech and Pharmadrug pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.